WallStreetZenWallStreetZen

NASDAQ: COLL
Collegium Pharmaceutical Inc Stock

$31.95+0.07 (+0.22%)
Updated Jun 13, 2024
COLL Price
$31.95
Fair Value Price
$55.94
Market Cap
$1.05B
52 Week Low
$20.83
52 Week High
$40.95
P/E
11.37x
P/B
4.7x
P/S
2.21x
PEG
0.33x
Dividend Yield
N/A
Revenue
$566.92M
Earnings
$93.29M
Gross Margin
60%
Operating Margin
36.89%
Profit Margin
16.5%
Debt to Equity
4.02
Operating Cash Flow
$309M
Beta
0.93
Next Earnings
Aug 1, 2024
Ex-Dividend
N/A
Next Dividend
N/A

COLL Overview

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how COLL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

COLL ($31.95) is undervalued by 42.88% relative to our estimate of its Fair Value price of $55.94 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
COLL ($31.95) is significantly undervalued by 42.88% relative to our estimate of its Fair Value price of $55.94 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
COLL ($31.95) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more COLL due diligence checks available for Premium users.

Be the first to know about important COLL news, forecast changes, insider trades & much more!

COLL News

Valuation

COLL fair value

Fair Value of COLL stock based on Discounted Cash Flow (DCF)
Price
$31.95
Fair Value
$55.94
Undervalued by
42.88%
COLL ($31.95) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
COLL ($31.95) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
COLL ($31.95) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

COLL price to earnings (PE)

For valuing profitable companies with steady earnings
Company
11.37x
Industry
1.36x
Market
30.48x
COLL is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
COLL is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

COLL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.7x
Industry
2.16x
COLL is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

COLL price to earnings growth (PEG)

For valuing profitable companies with growth potential
COLL is good value based... subscribe to Premium to read more.
PEG Value Valuation

COLL's financial health

Profit margin

Revenue
$144.9M
Net Income
$27.7M
Profit Margin
19.1%
COLL's Earnings (EBIT) of $209.16M... subscribe to Premium to read more.
Interest Coverage Financials
COLL's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.1B
Liabilities
$892.1M
Debt to equity
4.02
COLL's short-term assets ($539.26M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
COLL's short-term assets ($539.26M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
COLL's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
COLL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$61.9M
Investing
-$18.1M
Financing
-$54.1M
COLL's operating cash flow ($309.02M)... subscribe to Premium to read more.
Debt Coverage Financials

COLL vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
COLL$1.05B+0.22%11.37x4.70x
IRWD$950.56M-6.27%-0.88x-2.88x
CRON$939.75M-1.60%-17.57x0.87x
PCRX$1.32B-1.08%18.66x1.48x
ANIP$1.33B-1.51%39.04x2.93x

Collegium Pharmaceutical Stock FAQ

What is Collegium Pharmaceutical's quote symbol?

(NASDAQ: COLL) Collegium Pharmaceutical trades on the NASDAQ under the ticker symbol COLL. Collegium Pharmaceutical stock quotes can also be displayed as NASDAQ: COLL.

If you're new to stock investing, here's how to buy Collegium Pharmaceutical stock.

What is the 52 week high and low for Collegium Pharmaceutical (NASDAQ: COLL)?

(NASDAQ: COLL) Collegium Pharmaceutical's 52-week high was $40.95, and its 52-week low was $20.83. It is currently -21.98% from its 52-week high and 53.38% from its 52-week low.

How much is Collegium Pharmaceutical stock worth today?

(NASDAQ: COLL) Collegium Pharmaceutical currently has 32,715,322 outstanding shares. With Collegium Pharmaceutical stock trading at $31.95 per share, the total value of Collegium Pharmaceutical stock (market capitalization) is $1.05B.

Collegium Pharmaceutical stock was originally listed at a price of $12.29 in May 7, 2015. If you had invested in Collegium Pharmaceutical stock at $12.29, your return over the last 9 years would have been 159.97%, for an annualized return of 11.2% (not including any dividends or dividend reinvestments).

How much is Collegium Pharmaceutical's stock price per share?

(NASDAQ: COLL) Collegium Pharmaceutical stock price per share is $31.95 today (as of Jun 13, 2024).

What is Collegium Pharmaceutical's Market Cap?

(NASDAQ: COLL) Collegium Pharmaceutical's market cap is $1.05B, as of Jun 14, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Collegium Pharmaceutical's market cap is calculated by multiplying COLL's current stock price of $31.95 by COLL's total outstanding shares of 32,715,322.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.